MLL-r ALL represents a distinct leukemia with hyperleukocytosis, aggressive behavior with early relapse, relatively high incidence of central nervous system involvement and its epigenetically acting mechanism has been widely studied (Williams et al., 2019; El Chaer et al., 2020). Here, KMT2A is linked to leukemia.